CN107080078A - 一种仔猪用复合饲料添加剂及其制备方法和应用 - Google Patents
一种仔猪用复合饲料添加剂及其制备方法和应用 Download PDFInfo
- Publication number
- CN107080078A CN107080078A CN201710433891.3A CN201710433891A CN107080078A CN 107080078 A CN107080078 A CN 107080078A CN 201710433891 A CN201710433891 A CN 201710433891A CN 107080078 A CN107080078 A CN 107080078A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- feed
- piglet
- additive
- young
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 50
- 239000000654 additive Substances 0.000 title claims abstract description 25
- 230000000996 additive effect Effects 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 206010012735 Diarrhoea Diseases 0.000 claims abstract description 32
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 28
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 28
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 28
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 28
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 28
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 28
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 28
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 28
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 28
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 28
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 27
- 235000008397 ginger Nutrition 0.000 claims abstract description 27
- 239000002131 composite material Substances 0.000 claims abstract description 26
- 239000003674 animal food additive Substances 0.000 claims abstract description 21
- 239000011573 trace mineral Substances 0.000 claims abstract description 21
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 21
- 229940088594 vitamin Drugs 0.000 claims abstract description 21
- 229930003231 vitamin Natural products 0.000 claims abstract description 21
- 235000013343 vitamin Nutrition 0.000 claims abstract description 21
- 239000011782 vitamin Substances 0.000 claims abstract description 21
- 241001517299 Bulbophyllum Species 0.000 claims abstract description 20
- 241000522254 Cassia Species 0.000 claims abstract description 20
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 20
- 241001408636 Toxocarpus Species 0.000 claims abstract description 19
- OPGYRRGJRBEUFK-UHFFFAOYSA-L disodium;diacetate Chemical compound [Na+].[Na+].CC([O-])=O.CC([O-])=O OPGYRRGJRBEUFK-UHFFFAOYSA-L 0.000 claims abstract description 18
- 239000001632 sodium acetate Substances 0.000 claims abstract description 18
- 235000017454 sodium diacetate Nutrition 0.000 claims abstract description 18
- 230000036039 immunity Effects 0.000 claims abstract description 16
- 230000012010 growth Effects 0.000 claims abstract description 12
- 230000002829 reductive effect Effects 0.000 claims abstract description 12
- 241001092040 Crataegus Species 0.000 claims description 27
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 26
- 241000234314 Zingiber Species 0.000 claims description 26
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 18
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 14
- 229910052742 iron Inorganic materials 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 13
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 11
- 239000011691 vitamin B1 Substances 0.000 claims description 11
- 239000011701 zinc Substances 0.000 claims description 11
- 229910052725 zinc Inorganic materials 0.000 claims description 11
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 10
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 10
- 239000011572 manganese Substances 0.000 claims description 10
- 229910052748 manganese Inorganic materials 0.000 claims description 10
- 239000011669 selenium Substances 0.000 claims description 10
- 229910052711 selenium Inorganic materials 0.000 claims description 10
- 239000011726 vitamin B6 Substances 0.000 claims description 10
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 9
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 9
- 229930003427 Vitamin E Natural products 0.000 claims description 9
- 229910052802 copper Inorganic materials 0.000 claims description 9
- 239000010949 copper Substances 0.000 claims description 9
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 9
- 239000011630 iodine Substances 0.000 claims description 9
- 229910052740 iodine Inorganic materials 0.000 claims description 9
- 239000011647 vitamin D3 Substances 0.000 claims description 9
- 235000019165 vitamin E Nutrition 0.000 claims description 9
- 239000011709 vitamin E Substances 0.000 claims description 9
- 229940046009 vitamin E Drugs 0.000 claims description 9
- 229960002685 biotin Drugs 0.000 claims description 7
- 235000020958 biotin Nutrition 0.000 claims description 7
- 239000011616 biotin Substances 0.000 claims description 7
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 7
- 229930003448 Vitamin K Natural products 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 6
- 235000019168 vitamin K Nutrition 0.000 claims description 6
- 239000011712 vitamin K Substances 0.000 claims description 6
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 6
- 229940046010 vitamin k Drugs 0.000 claims description 6
- 241000723347 Cinnamomum Species 0.000 claims description 5
- 235000017803 cinnamon Nutrition 0.000 claims description 5
- 241000282887 Suidae Species 0.000 claims description 4
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 4
- YJRCNAAPGQBVFS-UHFFFAOYSA-N 4-amino-3-methylnaphthalen-1-ol Chemical compound C1=CC=CC2=C(N)C(C)=CC(O)=C21 YJRCNAAPGQBVFS-UHFFFAOYSA-N 0.000 claims description 3
- 241000675108 Citrus tangerina Species 0.000 claims description 3
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 3
- XWCYDHJOKKGVHC-UHFFFAOYSA-N Vitamin A2 Chemical compound OCC=C(C)C=CC=C(C)C=CC1=C(C)C=CCC1(C)C XWCYDHJOKKGVHC-UHFFFAOYSA-N 0.000 claims 2
- OBODKGDXEIUEIH-DAWLFQHYSA-N all-trans-3-hydroxyretinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CC(O)CC1(C)C OBODKGDXEIUEIH-DAWLFQHYSA-N 0.000 claims 1
- DPRNENKPXAZQBI-UHFFFAOYSA-N alpha-Vitamin A Natural products OCC=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C DPRNENKPXAZQBI-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 235000013372 meat Nutrition 0.000 abstract description 7
- 241001465754 Metazoa Species 0.000 abstract description 6
- 230000003993 interaction Effects 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 230000009467 reduction Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 39
- 241000282898 Sus scrofa Species 0.000 description 26
- 230000006870 function Effects 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 210000002966 serum Anatomy 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 12
- 239000003814 drug Substances 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 7
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 7
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 210000001835 viscera Anatomy 0.000 description 7
- 235000019155 vitamin A Nutrition 0.000 description 7
- 239000011719 vitamin A Substances 0.000 description 7
- 229940045997 vitamin a Drugs 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 235000021053 average weight gain Nutrition 0.000 description 5
- 230000034994 death Effects 0.000 description 5
- 230000001079 digestive effect Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 4
- 102000004889 Interleukin-6 Human genes 0.000 description 4
- 108090001005 Interleukin-6 Proteins 0.000 description 4
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 4
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 102000003777 Interleukin-1 beta Human genes 0.000 description 3
- 108090000193 Interleukin-1 beta Proteins 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 235000021050 feed intake Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- OPFTUNCRGUEPRZ-QLFBSQMISA-N (-)-beta-elemene Chemical compound CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- QRMPRVXWPCLVNI-YYFQZIEXSA-N Curcumol Chemical compound C1C(=C)[C@@H]2CC[C@H](C)[C@@]22C[C@@H](C(C)C)[C@]1(O)O2 QRMPRVXWPCLVNI-YYFQZIEXSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 241000607764 Shigella dysenteriae Species 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical group C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OPFTUNCRGUEPRZ-UHFFFAOYSA-N (+)-beta-Elemen Natural products CC(=C)C1CCC(C)(C=C)C(C(C)=C)C1 OPFTUNCRGUEPRZ-UHFFFAOYSA-N 0.000 description 1
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 1
- QRMPRVXWPCLVNI-UHFFFAOYSA-N Curcumenol Natural products C1C(=C)C2CCC(C)C22CC(C(C)C)C1(O)O2 QRMPRVXWPCLVNI-UHFFFAOYSA-N 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 102100031416 Gastric triacylglycerol lipase Human genes 0.000 description 1
- 206010017999 Gastrointestinal pain Diseases 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 240000004064 Poterium sanguisorba Species 0.000 description 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241001504477 Pycnonotidae Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241001627955 Tetraodon lineatus Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 239000010231 banlangen Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- -1 camphor terpene Chemical class 0.000 description 1
- 239000001772 cananga odorata hook. f. and thomas. oil Substances 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 108010091264 gastric triacylglycerol lipase Proteins 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000007666 subchronic toxicity Effects 0.000 description 1
- 231100000195 subchronic toxicity Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000033772 system development Effects 0.000 description 1
- 230000028016 temperature homeostasis Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/02—Breeding vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Fodder In General (AREA)
Abstract
本发明公开了一种仔猪用复合饲料添加剂及其制备方法和应用，属于兽用复合饲料添加剂技术领域。所述仔猪用复合饲料添加剂是由复合预混料与维生素和微量元素组成，所述复合预混料按重量份数为：山楂60‑70g、陈皮20‑30g、肉桂5‑10g、生姜3‑5g、弓果藤3‑5g、肥猪草3‑5g、双乙酸钠0.1‑0.3g。本发明的仔猪用复合饲料添加剂以天然植物为原料，佐以维生素和微量元素；无毒副作用，在各组分相互配合，相互作用下，既能降低仔猪的肉料比，还能提高仔猪的免疫力、降低腹泻率；从而提高仔猪的生长速度。
Description
技术领域
本发明涉及兽用复合饲料添加剂技术领域，具体涉及一种仔猪用复合饲料添加剂及其制备方法和应用。
背景技术
仔猪培育是养殖生产的基础阶段，仔猪的好坏直接影响整个饲养期猪的生长速度和饲料转化率，关系到猪场的经济效益。仔猪生长缓慢、容易腹泻是目前我国养猪生产中存在的主要问题，也是制约养猪业发展的一个瓶颈。仔猪具有以下生理特点：1.肠胃容积小、运动机能微弱，酶系统发育不完善，胃肠酸性低等限制了养分的吸收；2.体温调节能力差，尤其对寒冷的调节效率极低；3.生长强度高，具有高能、高蛋白的营养特点；4.免疫机能不全，仔猪10日龄后才开始产生抗体，但直到30-35天数量都很少；5.母乳中铁的含量极低，仔猪不能依靠母乳获得足够的铁。以上特点是造成仔猪生长缓慢、易腹泻的生理基础，而腹泻更可导致仔猪生长停滞，甚至生长倒退，严重者引起死亡。
饲料营养直接与仔猪断奶后生理紊乱有关，仔猪的早期补料有助于消化道的逐步适应、促进消化酶、消化液的分泌，并且饲喂开食料的仔猪能较好的保持肠壁的完整性，但早期补料并不总能促进胃肠发育及消化酶合成。仔猪饲料存在两个方面的消化障碍：一是蛋白质消化障碍，仔猪的大肠发酵功能尚未发育完全，不能很好的利用非消化蛋白质，未被分解、吸收的氨基酸进入肠道后，被大肠杆菌等分解，产生尸胺、组胺等有毒物质，刺激肠壁，引起腹泻。二是较高水平的碳水化合物饲料影响蛋白质的利用、吸收，仔猪消化酶不足且活力低，难以消化较高水平的碳水化合物饲料，导致肠道功能紊乱而消化不良。此外高蛋白质水平亦会由于植物蛋白的过敏反应而引起仔猪拉稀。因此配制仔猪饲料不仅要考虑各种营养成分的含量，还要考虑蛋白源的种类，避免使用过高的蛋白水平，适宜的非淀粉多糖含量亦很重要，在此基础上配制饲料还应尽可能防止仔猪拉稀，增强其免疫力。
发明内容
针对现有技术中仔猪培育存在的问题，本发明提供一种仔猪用复合饲料添加剂及其制备方法，其配方结合仔猪生理特点，有效解决饲料消化障碍，提高仔猪免疫力，减少腹泻，具有显著的促生长效果。
为了达到上述目的，本发明的技术方案如下：
一种仔猪用复合预混料，由以下重量的组分制备而成：山楂60-70g、陈皮20-30g、肉桂5-10g、生姜3-5g、弓果藤3-5g、肥猪草3-5g、双乙酸钠0.1-0.3g。
在上述方案的基础上，所述仔猪用复合预混料，由以下重量的组分制备而成：山楂65g、陈皮25g、肉桂6g、生姜4g、弓果藤4g、肥猪草4g、双乙酸钠0.2g。
一种仔猪用复合饲料添加剂，由复合预混料与维生素和微量元素组成，所述复合预混料为：山楂60-70g、陈皮20-30g、肉桂5-10g、生姜3-5g、弓果藤3-5g、肥猪草3-5g、双乙酸钠0.1-0.3g；所述维生素和微量元素为：维生素A 200000-310000IU、维生素D3 60000-80000IU、维生素E 1000-1500IU、维生素K 65-75mg、维生素B1 70-80mg、维生素B6 80-100mg、D-泛酸700-1000mg、生物素1.5-2.2mg、铜3750-4500mg、铁4700-5500mg、锌3000-4000mg、锰1500-2500mg、碘25-35mg、硒6-12mg。
在上述方案的基础上，所述复合预混料为：山楂65g、陈皮25g、肉桂6g、生姜4g、弓果藤4g、肥猪草4g、双乙酸钠0.2g；所述维生素和微量元素为：维生素A 300000IU、维生素D367000IU、维生素E 1250IU、维生素K70mg、维生素B1 75mg、维生素B6 90mg、D-泛酸900mg、生物素1.6mg、铜4000mg、铁5000mg、锌3500mg、锰2000mg、碘30mg、硒6mg。
在上述方案的基础上，所述仔猪用复合饲料添加剂的制备方法，步骤如下：
1)将山楂和肉桂分别经粉碎机粉碎，过60目筛获得山楂粉和肉桂粉；将陈皮和生姜分别经粉碎机粉碎，过100目筛获得陈皮粉和生姜粉；将弓果藤、肥猪草经过粉碎机粉碎至700目；将上述组分按重量份数混合，加入双乙酸钠粉末，投入搅拌机混合均匀即得复合预混料；
2)按量准确称取维生素和微量元素，混合均匀后，喷洒入复合预混料中，搅拌机中搅拌均匀后即得复合饲料添加剂。
在上述方案的基础上，所述方法制备的仔猪用复合饲料添加剂的用途，用于提高仔猪的生长速度、降低仔猪的腹泻率、提高仔猪的免疫力。
一种提高仔猪的生长速度、降低仔猪的腹泻率、提高仔猪的免疫力的饲料，是在饲料中添加上述方法制备的仔猪用复合饲料添加剂，添加量为3-6％。
在上述方案的基础上，所述提高仔猪的生长速度、降低仔猪的腹泻率、提高仔猪的免疫力的饲料，是在饲料中添加上述方法制备的仔猪用复合饲料添加剂，添加量为4％。
本发明各中药组分的药性如下：
山楂：味酸、甘、性微温；归脾、胃、肝经；功能主治：消食健胃，行气散瘀。用于肉食积滞，胃脘胀满，泻痢腹痛，瘀血经闭，产后瘀阻，心腹刺痛，疝气疼痛；高脂血症。焦山楂消食导滞作用增强。用于肉食积滞，泻痢不爽。
山楂作为一种中草药，含有柠檬酸、苹果酸、酒石酸、黄酮类、多糖类、蛋白质、脂肪及苷类等，其中5种水溶性维生素：维生素B1、维生素B2、维生素B6、维生素C以及维生素PP含量丰富，尤其是维生素C含量特别高。另外山楂中还含有钙、镁、铁、锌、硒等微量元素。山楂具有消食化积、抗菌消炎等功效，对大肠杆菌、痢疾杆菌、以及绿脓杆菌等有较强的抑制作用。有关研究表明，山楂中含有的山楂酸、酒石酸等有机酸能增加胃中消化酶的分泌，提高胃脂肪酶、蛋白酶的活性，进而促进消化和养分的吸收利用；其中柠檬酸亦可降低腹泻的发病率。
陈皮：味苦、辛，性温。归肺、脾经。功能主治：理气健脾，燥湿化痰。用于胸脘胀满，食少吐泻，咳嗽痰多。陈皮具有药物、营养双重功效，是一种绿色、高效、安全的中药饲料添加剂，其中含有丰富的粗蛋白、粗纤维、铁、锌、锰等多种矿物元素和维生素B1、维生素C。陈皮不仅营养丰富，而且含有天然健康的挥发性物质，风味独特，可以掩盖某些饲料成分的不良气味，从而提高饲料的适口性，增进采食量，是其他化学诱食剂无法比拟的。除此之外，现代研究表明，陈皮还可明显提高动物的免疫功能，具有广谱的抑菌作用。
肉桂：味辛、甘，性大热。归肾、脾、心、肝经。功能主治：补火助阳，引火归源，散寒止痛，活血通经。用于阳痿，宫冷，腰膝冷痛，肾虚作喘，阳虚眩晕，目赤咽痛，心腹冷痛，虚寒吐泻，寒疝，奔豚，经闭，痛经。
肉桂粉中含有桂皮醛、柠檬烯、β-榄香烯、依兰油烯、香豆素、桂皮醇、桂皮酸等营养物质，具有明显的杀灭病毒、抑制病毒的作用，对大肠杆菌、枯草杆菌及金黄葡萄菌、白色葡萄球菌、志贺氏痢疾杆菌、伤寒和副伤寒杆菌、肺炎球菌、产气杆菌、变形杆菌、炭疽杆菌、肠炎沙门氏菌、霍乱弧菌等有抑制作用。肉桂粉还是一种食用香料，其芳香性可增加动物采食量，同时对肠胃有缓和的刺激作用，可促进唾液及胃液分泌，增强消化功能，解除胃肠平滑肌痉挛，缓解肠道痉挛性疼痛。
生姜：味辛，性微温。归肺、脾、胃经。功能主治：解表散寒，温中止呕，化痰止咳。用于风寒感冒，胃寒呕吐，寒痰咳嗽。
生姜粉的主要有效成分为姜黄素、姜油萜、水茴香萜、樟脑萜、姜酚、姜烯、辣素、姜黄酮、姜黄醇等，此外还有大量的淀粉和蛋白质等营养成分。近年来的研究表明，生姜具有广泛的药理作用和饲用价值：(1)既有加速血液循环，刺激胃液分泌，兴奋肠道蠕动作用；(2)发汗、解毒等功能；(3)具有抗氧化功能；(4)捕捉自由基，减少疾病威胁；(5)增强动物体内防御功能、提高免疫力；(6)具有肠胃保健功效，减缓胃溃疡相关症状；(7)具有抗发炎和抑制病原微生物的功能。
弓果藤：味苦、辛、性凉；归脾；胃经；功能主治：清热解毒；祛瘀止痛。主痈肿疮毒；跌打瘀痛。
肥猪草：味甘；淡；性凉；归肝经；功能主治：清热。主肺热咳嗽；肝炎。
组方中：山楂、陈皮健脾胃、理气，两药共为君；肉桂、生姜温暖脾胃共为臣，更大的发挥山楂、陈皮的药效，有效的增进仔猪食欲；君臣两药性温热，容易使仔猪积热，再者山楂、陈皮肉桂、生姜在增进了仔猪采食量的同时，也会使仔猪身体产生积热，随着积热的增多，仔猪采食量会逐渐下降、免疫力也会逐渐下降，最终不但会影响其生长发育，而且还会引发其他疾病，为了有效解决这一问题，在组方中佐以弓果藤和肥猪草清热，配合君臣两药调节仔猪寒热平衡，提高仔猪免疫力。同时，在组方中复配入双乙酸钠，与中药成分相互协同，在有效增进仔猪食欲的前提下，有效提高所食用饲料的转化率。
本发明的有益效果
本发明的仔猪用复合饲料添加剂含有中药成分、维生素和微量元素，具有效果良好，价格低廉，毒副作用甚微，几乎无残留、无抗药性、不污染环境等特点。各种原料协同作用，通过以下几个方面促进仔猪肯吃快长不腹泻：一，增进食欲，通过增强营养物质的消化吸收和体内的合成代谢，促进仔猪的生长发育；二，提高仔猪免疫机能，增强抵抗力和抗应激能力；三，具有抗菌保健作用，能抑制多种病毒、微生物，降低仔猪腹泻发病率。
本发明仔猪用复合饲料添加剂中的双乙酸钠不仅具有抑菌作用，还能显著提高饲料的转化率；本发明复合饲料添加剂的各组分相互配合，相互作用，从而达到降低仔猪肉料比、提高仔猪的生长速度、降低仔猪的腹泻率并提高仔猪免疫力的目的。
具体实施方式
在本发明中所使用的术语，除非有另外说明，一般具有本领域普通技术人员通常理解的含义。
下面结合具体实施例，并参照数据进一步详细的描述本发明。以下实施例只是为了举例说明本发明，而非以任何方式限制本发明的范围。
实施例1
一种仔猪用复合饲料添加剂，是由复合预混料与维生素和微量元素组成。
所述复合预混料为：
山楂60g、陈皮20g、肉桂5g、生姜3g、弓果藤3g、肥猪草3g、双乙酸钠0.1g；
所述维生素和微量元素为：
维生素A 200000IU、维生素D3 60000IU、维生素E 1000IU、维生素K 65mg、维生素B170mg、维生素B6 80mg、D-泛酸700mg、生物素1.5mg、铜3750mg、铁4700mg、锌3000mg、锰1500mg、碘25mg、硒6mg。
仔猪用复合饲料添加剂的制备方法，具体步骤如下：
1)将山楂和肉桂分别经粉碎机粉碎，过60目筛获得山楂粉和肉桂粉；将陈皮和生姜分别经粉碎机粉碎，过100目筛获得陈皮粉和生姜粉；将弓果藤、肥猪草经过粉碎机粉碎至700目；将上述组分按重量份数混合，加入双乙酸钠粉末，投入搅拌机混合均匀即得复合预混料；
2)按量准确称取维生素和微量元素，混合均匀后，喷洒入复合预混料中，搅拌机中搅拌均匀后即得复合饲料添加剂。
实施例2
一种仔猪用复合饲料添加剂，是由复合预混料与维生素和微量元素组成。
所述复合预混料为：
山楂65g、陈皮25g、肉桂6g、生姜4g、弓果藤4g、肥猪草4g、双乙酸钠0.2g；
所述维生素和微量元素为：
维生素A 300000IU、维生素D3 67000IU、维生素E 1250IU、维生素K70mg、维生素B175mg、维生素B6 90mg、D-泛酸900mg、生物素1.6mg、铜4000mg、铁5000mg、锌3500mg、锰2000mg、碘30mg、硒6mg。
制备方法同实施例1。
实施例3
一种仔猪用复合饲料添加剂，是由复合预混料与维生素和微量元素组成。
所述复合预混料为：
山楂67g、陈皮27g、肉桂8g、生姜4g、弓果藤5g、肥猪草3g、双乙酸钠0.3g；
所述维生素和微量元素为：
维生素A 310000IU、维生素D3 80000IU、维生素E 1500IU、维生素K 75mg、维生素B180mg、维生素B6 100mg、D-泛酸1000mg、生物素2.2mg、铜4500mg、铁5500mg、锌4000mg、锰2500mg、碘35mg、硒12mg。
制备方法同实施例1。
实施例4
一种仔猪用复合饲料添加剂，是由复合预混料与维生素和微量元素组成。
所述复合预混料为：
山楂70g、陈皮30g、肉桂10g、生姜5g、弓果藤5g、肥猪草5g、双乙酸钠0.3g；
所述维生素和微量元素为：
维生素A 250000IU、维生素D3 75000IU、维生素E 1350IU、维生素K 73mg、维生素B177mg、维生素B6 95mg、D-泛酸800mg、生物素1.8mg、铜4250mg、铁5250mg、锌3750mg、锰2250mg、碘32mg、硒8mg。
制备方法同实施例1。
一、毒性试验
1.1试验方法
选取体重为18～22g的ICR鼠120只，经3天适应性饲养后，随机均分为5组(雌雄各半)，实施例1组、实施例2组、实施例3组、实施例4组和空白对照组，每组25只；空白对照组灌胃生理盐水，实施例1-4组是将各实施例制备的复合饲料添加剂溶于水后灌服；实施例1-4组的给药量为60g/kg，连续7天。
1.2测定指标
1.2.1观察试验鼠的精神状态、饮食情况，记录发病死亡情况。
1.2.2测定试验鼠的血清生化指标。
1.2.3解剖试验鼠，观察脏器变化并测定脏器指数(脏器指数＝脏器重/体重×100)。
1.3结果与分析
所有采集数据采用Excel软件进行前期处理，然后用SPSS20.0进行统计分析，LSD进行多重比较，结果采用平均值±标准差表示。
1.3.1试验鼠发病和死亡情况
试验期间，对照组和试验组鼠的精神状态，饮食情况未见明显异常；鼠发病和死亡情况如表1所示。
表1鼠发病和死亡情况
| 组别 | 总数(只) | 死亡(只) | 死亡率％ |
| 实施例1 | 25 | 0 | 0 |
| 实施例2 | 25 | 0 | 0 |
| 实施例3 | 25 | 0 | 0 |
| 实施例4 | 25 | 0 | 0 |
| 对照组 | 25 | 0 | 0 |
1.3.2试验鼠的血清生化指标
试验结束后，扑杀鼠，采取血液分离血清，测定各生化指标如表2所示。
表2试验鼠血清生化指标情况
由表2可以看出，各实验组之间鼠血清生化指标相比无显著差异，表明本发明复合饲料添加剂对肝功能和肾功能无不良影响。
1.3.3试验鼠的脏器指标
实验结束后，扑杀鼠，解剖并观察内脏未见异常，称量各脏器重量，并计算脏器指数如表3所示。
表3试验鼠脏器指标情况
| 组别 | 肝脏指数 | 肾脏指数 | 心脏指数 | 肺脏指数 | 脾脏指数 |
| 实施例1 | 54.96±1.39 | 13.42±0.35 | 4.55±0.22 | 6.88±0.58 | 5.21±0.44 |
| 实施例2 | 55.19±1.33 | 13.96±0.23 | 4.67±0.19 | 6.94±0.45 | 5.42±0.37 |
| 实施例3 | 55.11±1.05 | 13.57±0.28 | 4.60±0.21 | 6.91±0.42 | 5.38±0.40 |
| 实施例4 | 55.04±1.27 | 13.72±0.21 | 4.62±0.24 | 6.93±0.47 | 5.40±0.41 |
| 对照组 | 54.86±1.58 | 13.49±0.31 | 4.51±0.20 | 6.82±0.51 | 5.03±0.47 |
由表3可知，各试验组与对照组之间，鼠的脏器指标无显著变化。
1.4亚慢性毒性试验
将本发明实施例制备的复合饲料添加剂按60g/kg给药ICR鼠连续灌胃1个月，动物的精神状态、饮食情况、血清生化指标以及脏器指数未见明显异常，停药两周后检查以上各指标无明显毒性反应，表明无蓄积毒性。
二、效果试验
2.1试验组方
2.1.1试验组1：本发明实施例1的复合饲料添加剂
2.1.2试验组2：本发明实施例2的复合饲料添加剂
2.1.3试验组3：本发明实施例3的复合饲料添加剂
2.1.4试验组4：本发明实施例4的复合饲料添加剂
2.1.5预混料组：现有的中草药复合预混料(维生素A 300000IU；维生素D365000IU；维生素E 1000IU；维生素K 70mg；维生素B1 75mg；维生素B6 90mg；D-泛酸900mg；生物素1.6mg；铜4000mg；铁5000mg；锌3500mg；锰2000mg；碘30mg；硒6mg；中草药：山楂、麦芽各50g，板蓝根、陈皮、苍术、黄精、白头翁各25g，地榆、生姜各12.5g)
2.1.6对照组1：本发明实施例2不含山楂、陈皮的复合饲料添加剂
2.1.7对照组2：本发明实施例2不含肉桂、生姜的复合饲料添加剂
2.1.8对照组3：本发明实施例2不含弓果藤、肥猪草的复合饲料添加剂
2.1.9对照组4：本发明实施例2不含双乙酸钠的复合饲料添加剂
2.2试验方法
选择日龄胎次、体重基本一致的健康断奶仔猪540头，随机分成9组，每组60头，各组公母基本一致。9组分别按照2.1的试验组方处理，每组投喂一种复合饲料添加剂，2.1.1-2.1.4的试验组方分别记为试验组1-4；2.1.6-2.1.9的试验组方分别记为对照组1-4，试验组和对照组均是在常规日粮(玉米62.5％、豆粕25.2％、鱼粉6％、赖氨酸1％、食用油3％、磷酸氢钙2％、食盐0.3％)中添加重量百分含量为4％的复合饲料添加剂；添加中草药复合预混料组记为预混料组，是在常规日粮中添加重量百分含量为4％的预混料。
试验数据：分组后，先进行1周的预试验，调节各组体重，然后进入30天的试验期。统计30天试验期内仔猪平均增重、平均日采食量、平均料肉比和腹泻发病率，并测定血清免疫指标。腹泻发病率(％)＝100×各重复累计腹泻猪只头次数/各重复总饲养头次数。
2.3试验结果
2.3.1仔猪的生长性能
仔猪平均增重、平均日采食量、平均料肉比和腹泻发病率如表4所示。
表4试验期仔猪增重、日采食量、料肉比和腹泻发病率统计
| 组别 | 增重(kg) | 日采食量(g) | 料肉比(％) | 腹泻发病率(％) |
| 试验组1 | 13.21 | 574 | 1.30 | 3.24±0.97 |
| 试验组2 | 14.32 | 603 | 1.26 | 2.89±0.81 |
| 试验组3 | 13.87 | 592 | 1.28 | 3.32±0.48 |
| 试验组4 | 14.18 | 601 | 1.27 | 3.11±0.63 |
| 预混料组 | 12.81 | 630 | 1.48 | 4.87±0.76 |
| 对照组1 | 11.53 | 628 | 1.63 | 7.58±0.35 |
| 对照组2 | 12.19 | 615 | 1.51 | 6.34±0.55 |
| 对照组3 | 11.89 | 603 | 1.52 | 8.13±0.72 |
| 对照组4 | 13.04 | 590 | 1.36 | 3.61±0.90 |
以上试验结果说明，添加本发明复合饲料添加剂的试验组仔猪的平均增重较对照组和预混料组高，平均肉料比和平均腹泻发病率则显著低于对照组和预混料组，实施例2复合饲料添加剂优于实施例1、3和4。对照组1、2平均增重显著低于试验组和预混料组，而对照组3、4平均增重高于预混料组，低于试验组；对照组1、2的平均肉料比和平均腹泻发病率高于试验组和预混料组，对照组3、4的平均肉料比和平均腹泻发病率则低于预混料组，高于试验组；特别是对照组3，从数据中可以发现：当组方中去掉弓果藤、肥猪草之后，仔猪的腹泻发病率明显增加，而试验组1-4腹泻发病率显著低于其他对照组。
2.3.2血清免疫指标
试验结束后，静脉抽血，静置，取上清。用试剂盒检测仔猪血清免疫指标IgG、IL-1β、IL-6、TNF-α、CD4+和CD8+。结果如表5所示。
表5仔猪血清免疫指标
由表5可知，试验组1-4仔猪血清中IgG、IL-1β、IL-6和TNF-α的含量显著高于预混料剂组和对照组，这说明本发明的复合饲料添加剂能显著提高仔猪的免疫力；血清中CD4+和CD8+的含量试验组相对于预混料组和对照组有所提高，但未达到显著差异。实施例2复合饲料添加剂优于实施例1、3和4。对照组1、2仔猪血清中IgG、IL-1β、IL-6和TNF-α的含量低于试验组和预混料组，而对照组3、4仔猪血清中IgG、IL-1β、IL-6和TNF-α的含量高于预混料组，低于试验组；对照组1、2血清中CD4+和CD8+的含量低于试验组和预混料组，对照组3、4血清中CD4+和CD8+的含量则高于预混料组，低于试验组，未达到显著差异。
综上所述，本发明制备的复合饲料添加剂适口性好，具有消食化积，促进消化吸收，增强免疫力，降低腹泻发病率等功效，从而提高饲料利用率，促进仔猪肯吃快长不腹泻。
上述实施方案为本发明最佳的实施方案，但本发明的实施方案并不受上述实施方案的限制，其他的任何不违背本发明原理的条件下，可以通过改变参数的形式所产生的实施例，都包含于本发明的保护范围之内。
Claims (8)
1.一种仔猪用复合预混料，其特征在于：由以下重量的组分制备而成：山楂60-70g、陈皮20-30g、肉桂5-10g、生姜3-5g、弓果藤3-5g、肥猪草3-5g、双乙酸钠0.1-0.3g。
2.根据权利要求1所述仔猪用复合预混料，其特征在于：由以下重量的组分制备而成：山楂65g、陈皮25g、肉桂6g、生姜4g、弓果藤4g、肥猪草4g、双乙酸钠0.2g。
3.一种仔猪用复合饲料添加剂，其特征在于：由复合预混料与维生素和微量元素组成，所述复合预混料为：山楂60-70g、陈皮20-30g、肉桂5-10g、生姜3-5g、弓果藤3-5g、肥猪草3-5g、双乙酸钠0.1-0.3g；所述维生素和微量元素为：维生素A200000-310000IU、维生素D360000-80000IU、维生素E 1000-1500IU、维生素K 65-75mg、维生素B1 70-80mg、维生素B680-100mg、D-泛酸700-1000mg、生物素1.5-2.2mg、铜3750-4500mg、铁4700-5500mg、锌3000-4000mg、锰1500-2500mg、碘25-35mg、硒6-12mg。
4.根据权利要求3所述仔猪用复合饲料添加剂，其特征在于：所述复合预混料为：山楂65g、陈皮25g、肉桂6g、生姜4g、弓果藤4g、肥猪草4g、双乙酸钠0.2g；所述维生素和微量元素为：维生素A300000IU、维生素D3 67000IU、维生素E 1250IU、维生素K70mg、维生素B1 75mg、维生素B6 90mg、D-泛酸900mg、生物素1.6mg、铜4000mg、铁5000mg、锌3500mg、锰2000mg、碘30mg、硒6mg。
5.根据权利要求3或4任一项所述仔猪用复合饲料添加剂的制备方法，其特征在于：步骤如下：
1)将山楂和肉桂分别经粉碎机粉碎，过60目筛获得山楂粉和肉桂粉；将陈皮和生姜分别经粉碎机粉碎，过100目筛获得陈皮粉和生姜粉；将弓果藤、肥猪草经过粉碎机粉碎至700目；将上述组分按重量混合，加入双乙酸钠粉末，投入搅拌机混合均匀即得复合预混料；
2)按量准确称取维生素和微量元素，混合均匀后，喷洒入复合预混料中，搅拌机中搅拌均匀后即得复合饲料添加剂。
6.根据权利要求5所述方法制备的仔猪用复合饲料添加剂的用途，其特征在于：用于提高仔猪的生长速度、降低仔猪的腹泻率、提高仔猪的免疫力。
7.一种提高仔猪的生长速度、降低仔猪的腹泻率、提高仔猪的免疫力的饲料，其特征在于：在饲料中添加权利要求5所述方法制备的仔猪用复合饲料添加剂，添加量为3-6％。
8.根据权利要求7所述提高仔猪的生长速度、降低仔猪的腹泻率、提高仔猪的免疫力的饲料，其特征在于：在饲料中添加权利要求5所述方法制备的仔猪用复合饲料添加剂，添加量为4％。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710433891.3A CN107080078A (zh) | 2017-06-09 | 2017-06-09 | 一种仔猪用复合饲料添加剂及其制备方法和应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710433891.3A CN107080078A (zh) | 2017-06-09 | 2017-06-09 | 一种仔猪用复合饲料添加剂及其制备方法和应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107080078A true CN107080078A (zh) | 2017-08-22 |
Family
ID=59605611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710433891.3A Pending CN107080078A (zh) | 2017-06-09 | 2017-06-09 | 一种仔猪用复合饲料添加剂及其制备方法和应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107080078A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108497191A (zh) * | 2018-04-18 | 2018-09-07 | 南宁学院 | 一种仔猪诱食剂及其制备方法 |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102293328A (zh) * | 2010-06-23 | 2011-12-28 | 北京大北农科技集团股份有限公司 | 一种猪用中草药复合预混料 |
| CN104256098A (zh) * | 2014-10-15 | 2015-01-07 | 聊城大学 | 一种仔猪中草药饲料添加剂及其制备方法 |
| CN105146081A (zh) * | 2015-08-26 | 2015-12-16 | 蚌埠市蚌山区常宝养猪场 | 一种仔猪专用饲料添加剂及其制备方法 |
| CN106509337A (zh) * | 2016-10-15 | 2017-03-22 | 广西润爽生态农业科技有限公司 | 防治鱼肝胆疾病的饲料添加剂及其制备方法 |
| CN106538883A (zh) * | 2016-10-15 | 2017-03-29 | 广西润爽生态农业科技有限公司 | 一种鱼饲料及其制备方法 |
| CN106721635A (zh) * | 2016-12-09 | 2017-05-31 | 黄文庆 | 以茉莉花渣为原料制成的鱼饲料及其制备方法 |
| CN106721230A (zh) * | 2015-11-20 | 2017-05-31 | 刘振宇 | 一种仔猪饲料添加剂及其制备方法 |
| CN106798088A (zh) * | 2016-12-09 | 2017-06-06 | 安徽天泽饲料有限责任公司 | 一种饲料用增强免疫力的预混肉粉 |
-
2017
- 2017-06-09 CN CN201710433891.3A patent/CN107080078A/zh active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102293328A (zh) * | 2010-06-23 | 2011-12-28 | 北京大北农科技集团股份有限公司 | 一种猪用中草药复合预混料 |
| CN104256098A (zh) * | 2014-10-15 | 2015-01-07 | 聊城大学 | 一种仔猪中草药饲料添加剂及其制备方法 |
| CN105146081A (zh) * | 2015-08-26 | 2015-12-16 | 蚌埠市蚌山区常宝养猪场 | 一种仔猪专用饲料添加剂及其制备方法 |
| CN106721230A (zh) * | 2015-11-20 | 2017-05-31 | 刘振宇 | 一种仔猪饲料添加剂及其制备方法 |
| CN106509337A (zh) * | 2016-10-15 | 2017-03-22 | 广西润爽生态农业科技有限公司 | 防治鱼肝胆疾病的饲料添加剂及其制备方法 |
| CN106538883A (zh) * | 2016-10-15 | 2017-03-29 | 广西润爽生态农业科技有限公司 | 一种鱼饲料及其制备方法 |
| CN106721635A (zh) * | 2016-12-09 | 2017-05-31 | 黄文庆 | 以茉莉花渣为原料制成的鱼饲料及其制备方法 |
| CN106798088A (zh) * | 2016-12-09 | 2017-06-06 | 安徽天泽饲料有限责任公司 | 一种饲料用增强免疫力的预混肉粉 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108497191A (zh) * | 2018-04-18 | 2018-09-07 | 南宁学院 | 一种仔猪诱食剂及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103749982B (zh) | 用于提高产鸡蛋产量的饲料、中药添加剂和制备方法 | |
| CN102845638B (zh) | 一种防治禽流感的鸭饲料及其中药添加剂 | |
| CN102940155B (zh) | 一种樱桃谷鸭的雏鸭饲料及其制备方法 | |
| CN102805274B (zh) | 一种0-14日龄小麦型肉小鸭配合饲料及其制备方法 | |
| CN106819497A (zh) | 一种提高仔猪抗腹泻能力的饲料及其制备方法 | |
| CN102450523A (zh) | 一种肉鸭饲料及其中药添加剂 | |
| CN105432999A (zh) | 一种猪饲料及其制备方法 | |
| CN103750064B (zh) | 一种增强免疫力改善肉质的中草药复合猪饲料 | |
| CN104982751A (zh) | 一种米糠型仔猪配合饲料及其制备方法 | |
| CN103141682B (zh) | 一种含中草药的复合型鸭饲料 | |
| CN106858595A (zh) | 一种烧伤专用型临床营养配方及其制备方法 | |
| CN108719637A (zh) | 一种生长育肥猪用合生素饲料添加剂及制备方法及应用 | |
| CN103340291B (zh) | 改善畜禽肉质和鲜蛋品质的中草药饲料改良剂 | |
| CN106615973A (zh) | 一种蛋鸭饲料及其制备方法 | |
| CN106234822A (zh) | 蛋鸡产蛋期饲料及加工方法 | |
| CN105558379A (zh) | 一种微生物中草药猪饲料及其制备方法 | |
| CN104161204A (zh) | 一种促进猪生长的中药饲料添加剂及其应用 | |
| CN108771016A (zh) | 一种猪用中药饲料添加剂及其应用 | |
| CN107712414A (zh) | 一种提高抵抗力的鸡饲料 | |
| CN106729189A (zh) | 一种提高兔肉蛋白质含量的中草药饲料添加剂及制备方法 | |
| CN106720984A (zh) | 一种含中药的畜禽饲料及其制备方法 | |
| CN107080078A (zh) | 一种仔猪用复合饲料添加剂及其制备方法和应用 | |
| CN105432972A (zh) | 一种鲈鱼的富硒饲料添加剂 | |
| CN108056315A (zh) | 一种预防鸡白冠病的蛋鸡饲料 | |
| CN105231010A (zh) | 一种含辣木叶的鸡饲料及养鸡方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170822 |